The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...

What’s the Difference Between Nontherapeutic and Therapeutic? Benefits of Nontherapeutic Clinical Trials Examples of Nontherapeutic Clinical Trials How to Find a Nontherapeutic Clinical Trial When you ...

Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes. By using speech ...

Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing ...

Susan Vadaparampil, PhD, MPH, of Moffitt Cancer Center, concludes her conversation with The American Journal of Managed Care® at last month’s Institute for Value-Based Medicine ® event in Tampa, ...

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol deviations or delays in data entry. Importantly, these risks can be flagged ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

SEER-Medicare data show just 4% of older adults with blood cancers enter clinical trials, revealing disparities and fixable ...